IN8bio, Inc.
INAB
$1.80
-$0.11-5.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.23% | 24.34% | 8.22% | 9.90% | 13.07% |
| Total Depreciation and Amortization | -1.14% | -32.78% | 17.19% | -4.70% | 1.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75% | -27.54% | 14.92% | 0.73% | -54.39% |
| Change in Net Operating Assets | 276.72% | -55.42% | -161.64% | 53.39% | 139.70% |
| Cash from Operations | 39.30% | 10.26% | -25.78% | 22.49% | 34.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.76% | 47.44% | -4.00% | -2.74% | -2.82% |
| Issuance of Common Stock | 1,572.66% | -79.79% | 33.58% | -63.31% | 3,784.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | 1,769.46% | -81.22% | 35.29% | -65.20% | 10,754.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 744.97% | -289.18% | 73.80% | -89.18% | 214.64% |